Viramune to Atripla switch
May 21, 2007
Hello, after almost 10yrs on Combivir/Viramune looking to switch to Atripla. Have remained undetectable with no side effects just looking to go to 1 pill/day. Physician and I are trying to determine best transition with least likely development of resistance. Currently thinking OK to drop viramune same day start atripla but keep should keep taking combivir 2 more days. Please advise how you would make this switch? thx.
Response from Dr. Young
Thanks for your post.
The decision to switch shouldn't be done lightly- in your case, you've done very well for years and it seems as if the only reason to switch is to reduce the dosing frequency and pill count (not anything to trivialize). The proposed switch should be fine, provided that your viral load is undetectable.
The simple switch, droping the Combivir/Viramune and starting Atripla on the same day (in the evening) should suffice. Your drug levels should very quickly reach sufficient levels; there's no obvious reason to me why you'd need to continue Combivir any longer than the Viramune.
Hope this helps. Let us know how this turns out for you. BY
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Does HIV Cause Psoriasis?
- Sore On Mouth Sign Of Ars
- Swollen Lymph Nodes Sign Of Seroconversion
- Sex With A Prostitute Should I Get Test For AIDS
- Cold Feet After Oral Sex On A Woman What Are The Chances Of HIV
- Loose Stool After Receptive Anal Sex Without Condom What Are The Chances Of HIV
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.